Literature DB >> 9861565

Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun.

A Grzeszczuk1, E Sokolewicz-Bobrowska, D Prokopowicz.   

Abstract

Vaccination against tick-borne encephalitis with FSME-Immun vaccine was started in the Department of Infectious Diseases, University Medical School of Białystok, Poland, in 1992. No serious adverse reactions after vaccine administration were observed. Post-vaccine side effects were reported in 242 (11.3%) persons after the first dose (n = 2,135) and only in 14 patients (1.2%) after the second one (n = 1,183). These effects were mild and transitory. No relationship was observed between the frequency of adverse reactions, general or local, and the initial anti-TBE virus antibody titres or the age of the immunized individuals. Post-vaccine side effects were reported significantly more frequently among people not bitten by ticks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861565     DOI: 10.1007/BF02770841

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  16 in total

1.  Investigation of a natural focus of encephalitis in the "Puszcza Bialowiesk" national park.

Authors:  F PRZESMYCKI; Z TAYTSCH; Z WROBLEWSKA; J LACHMAYER
Journal:  J Infect Dis       Date:  1960 May-Jun       Impact factor: 5.226

2.  [Early summer meningoencephalitis vaccination].

Authors:  K Jellinger
Journal:  Dtsch Med Wochenschr       Date:  1992-08-21       Impact factor: 0.628

Review 3.  [Early summer meningoencephalitis vaccination. The indications and a critical assessment of the neurological vaccination complications].

Authors:  R Gold; H Wiethölter; I Rihs; J Löwer; L Kappos
Journal:  Dtsch Med Wochenschr       Date:  1992-01-17       Impact factor: 0.628

4.  Can we reduce the dose of a vaccine?

Authors:  G Rosenkranz
Journal:  Control Clin Trials       Date:  1997-02

5.  Neurological complications after simultaneous immunisation against tick-borne encephalitis and tetanus.

Authors:  M Schabet; H Wiethoelter; W Grodd; A Vallbracht; J Dichgans; W Becker; P A Berg
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

6.  [Reactions after vaccination against tick-borne encephalitis].

Authors:  H Vlasimská; H Smejkalová
Journal:  Epidemiol Mikrobiol Imunol       Date:  1995-03       Impact factor: 0.444

7.  Prevalence of antibodies against tick-borne encephalitis among residents of north-eastern Poland.

Authors:  D Prokopowicz; E Bobrowska; M Bobrowski; A Grzeszczuk
Journal:  Scand J Infect Dis       Date:  1995

8.  [Neurological side effects following vaccination of early-summer meningoencephalitis. Case report and experiences of the Swiss Center for Adverse Drug Effects].

Authors:  S Goerre; J Kesselring; K Hartmann; M Kuhn; W H Reinhart
Journal:  Schweiz Med Wochenschr       Date:  1993-04-10

9.  Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study.

Authors:  O E Girgsdies; G Rosenkranz
Journal:  Vaccine       Date:  1996-10       Impact factor: 3.641

10.  [The tick-borne encephalitis in Poland].

Authors:  J Zabicka
Journal:  Przegl Epidemiol       Date:  1994
View more
  4 in total

1.  Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops.

Authors:  Guillaume Desjeux; Laurent Galoisy-Guibal; Cyrille Colin
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  [Adverse ocular effects of vaccinations].

Authors:  T Ness; H Hengel
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

Review 3.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center.

Authors:  Thomas Ness; Daniel Boehringer; Sonja Heinzelmann
Journal:  Orphanet J Rare Dis       Date:  2017-04-27       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.